Breztri Aerosphere Patient Assistance Program
Don’t let the cost of Breztri Aerosphere endanger your health. We help eligible patients access this brand-name triple-therapy COPD inhaler for just $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Breztri Aerosphere is a triple-therapy COPD inhaler that reduces flare-ups, improves lung function, and helps you breathe more easily — all from a single device
- Retail price is approximately $798–$934/month without insurance; even with the best discount coupons, it still costs $553–$674/month
- AffordMyPrescriptions connects eligible patients with the Patient Assistance Program, providing access to brand-name Breztri for just $69.95 per month — saving you up to $10,300 or more per year
- No generic version of Breztri Aerosphere is available, and none is expected until at least 2030 — and potentially as late as 2038 — making Patient Assistance Programs the most effective pathway to affordable access
What Is Breztri Aerosphere Prescription Assistance Program?
The Breztri Aerosphere Prescription Assistance Program is a manufacturer-sponsored initiative that provides this COPD inhaler at no medication cost to patients who qualify based on income and insurance status. The program is available to uninsured patients, and notably, it also accepts Medicare Part D patients who cannot afford their medication — a significant advantage that many other assistance programs do not offer. Once approved, your medication is made available at no charge, and you can reapply as needed.
However, the application process involves eligibility verification, prescriber coordination,income documentation, and periodic re-enrollment — all of which can be overwhelming when you’re already managing a chronic lung condition. AffordMyPrescriptions handles all of this for you. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment, from initial application through ongoing refills and annual re-enrollment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refills and annual re- enrollment, so you never face a gap in your COPD treatment.
Pharmacy Price Comparison
- Without assistance, Breztri Aerosphere costs hundreds of dollars per month at retail pharmacies. Discount programs offer some relief, but they don’t come close to what a Patient Assistance Program provides if you qualify.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$710 | Save ~$640/mo |
| CVS Pharmacy | ~$730 | Save ~$660/mo |
| Walmart | ~$700 | Save ~$630/mo |
| Costco | ~$680 | Save ~$610/mo |
| Kroger | ~$572 | Save ~$502/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Breztri Aerosphere Prescription Program?
The Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long–term solution:
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Cards expire and require constant renewal
- Still $155–$340/month even with best discount
- Can’t be used with Medicare, Medicaid, or government insurance
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact Afford My Prescriptions directly so we can review your specific situation and determine if you qualify for assistance.
- You are a U.S. citizen or legal resident
- You have a valid Breztri Aerosphere prescription from a licensed U.S. healthcare provider for COPD maintenance treatment
- You are uninsured or underinsured and cannot afford your medication at current pharmacy prices
- You have Medicare Part D and are struggling with out-of-pocket drug costs (the program accepts Medicare patients)
- You have recently experienced a change in financial circumstances
Understanding Breztri Aerosphere:
Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) is a prescription triple-therapy inhaler used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It combines three medications in a single inhaler
to reduce inflammation, relax airway muscles, and open breathing passages.
Breztri is taken as two puffs twice daily — morning and evening — and is delivered through a pressurized metered-dose inhaler. It is not a rescue inhaler and is not approved for the treatment of asthma.
How It Works:
The three active ingredients work through different mechanisms to comprehensively manage COPD:
● Budesonide (Inhaled Corticosteroid): Reduces inflammation inside your airways, keeping them open and reducing flare-ups
● Glycopyrrolate (Anticholinergic): Relaxes airway muscles and widens breathing passages for improved airflow
● Formoterol Fumarate (Long-Acting Bronchodilator): Keeps airways relaxed and open for an extended period
Form and Use:
Available as a metered-dose inhaler providing 120 inhalations (30-day supply). Taken as 2 puffs twice daily, as prescribed by your doctor, with or without food. Rinse mouth with water after each use.
Generic Availability:
As of April 2026, there is no FDA-approved generic version of Breztri Aerosphere available in the United States. The earliest date for generic entry is estimated to be May 2030 at the soonest, with some patent protections extending as late as October 2038. This sustained absence of generic
competition ensures that the price will remain elevated, making Patient Assistance Programs the most impactful savings pathway.
Warnings:
This is a medication you cannot skip, reduce, or stop taking without risking a serious medical event. Stopping Breztri Aerosphere without medical supervision can significantly worsen your COPD symptoms and increase risk of serious flare-ups. Always consult your doctor before making changes to your treatment.
Budesonide: An inhaled corticosteroid that reduces inflammation inside your airways.
Glycopyrrolate: An anticholinergic that blocks acetylcholine, relaxing airway muscles and widening breathing passages.
.
Formoterol fumarate: a long-acting bronchodilator that keeps airways open for an extended period.
FAQ (Frequently Asked Questions)
Is this the same Breztri Aerosphere I’d get at a pharmacy?
Yes. The Breztri Aerosphere supplied through the assistance program is the exact same FDA-approved brand-name inhaler.
Is there a generic version of Breztri Aerosphere?
No. There is no FDA-approved generic, and none is expected until at least 2030 — with some patent protections extending as late as 2038.
Can I get Breztri through the PAP if I have Medicare?
Yes. Unlike many other assistance programs, the manufacturer’s program does accept Medicare Part D patients who cannot afford their medication.
How long does it take to get approved and receive my medication?
Typically 2 to 4 weeks from completed application to medication access. Our advocates work to expedite the process, and we can help you access bridge supplies or alternative savings while your application is being reviewed.
Take Control of Your Medication Costs
If you are struggling with the high cost of Breztri Aerosphere, our team may be able to help you
access assistance programs designed to make medications more affordable. Check your
eligibility today and take the first step toward reducing your prescription costs.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.